Follow
Lieuwe D. Bos
Lieuwe D. Bos
University of Amsterdam - Academic Medical Center
Verified email at amc.uva.nl
Title
Cited by
Cited by
Year
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ...
Science 370 (6515), eabd4585, 2020
17682020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ...
Science 370 (6515), eabd4570, 2020
15482020
High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial
PROVE Network Investigators
The Lancet 384 (9942), 495-503, 2014
4492014
Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis
LA van Vught, PMCK Klouwenberg, C Spitoni, BP Scicluna, MA Wiewel, ...
Jama 315 (14), 1469-1479, 2016
4352016
A European Respiratory Society technical standard: exhaled biomarkers in lung disease
I Horváth, PJ Barnes, S Loukides, PJ Sterk, M Högman, AC Olin, A Amann, ...
European Respiratory Journal 49 (4), 2017
4222017
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
3972021
Volatile metabolites of pathogens: a systematic review
LDJ Bos, PJ Sterk, MJ Schultz
PLoS pathogens 9 (5), e1003311, 2013
3882013
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
BP Scicluna, LA Van Vught, AH Zwinderman, MA Wiewel, EE Davenport, ...
The Lancet Respiratory Medicine 5 (10), 816-826, 2017
2842017
Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts
A Serpa Neto, RO Deliberato, AEW Johnson, LD Bos, P Amorim, ...
Intensive care medicine 44 (11), 1914-1922, 2018
2522018
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
2102021
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study
M Botta, AM Tsonas, J Pillay, LS Boers, AG Algera, LDJ Bos, ...
The lancet Respiratory medicine 9 (2), 139-148, 2021
1962021
Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis
LD Bos, LR Schouten, LA Van Vught, MA Wiewel, DSY Ong, O Cremer, ...
Thorax 72 (10), 876-883, 2017
1922017
Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients
PMCK Klouwenberg, DSY Ong, LDJ Bos, FM de Beer, ...
Critical care medicine 41 (10), 2373-2378, 2013
1832013
Electronic implementation of a novel surveillance paradigm for ventilator-associated events. Feasibility and validation
PMC Klein Klouwenberg, MSM van Mourik, DSY Ong, J Horn, MJ Schultz, ...
American journal of respiratory and critical care medicine 189 (8), 947-955, 2014
1642014
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
1572021
Increased incidence of co-infection in critically ill patients with influenza
I Martin-Loeches, M J Schultz, JL Vincent, F Alvarez-Lerma, LD Bos, ...
Intensive care medicine 43 (1), 48-58, 2017
1572017
Lung microbiota predict clinical outcomes in critically ill patients
RP Dickson, MJ Schultz, T van der Poll, LR Schouten, NR Falkowski, ...
American journal of respiratory and critical care medicine 201 (5), 555-563, 2020
1552020
Exhaled molecular fingerprinting in diagnosis and monitoring: validating volatile promises
AW Boots, LD Bos, MP van der Schee, FJ van Schooten, PJ Sterk
Trends in molecular medicine 21 (10), 633-644, 2015
1402015
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised …
APJ Vlaar, S de Bruin, M Busch, SA Timmermans, IE van Zeggeren, ...
The Lancet Rheumatology 2 (12), e764-e773, 2020
1312020
Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome
LDJ Bos, H Weda, Y Wang, HH Knobel, TME Nijsen, TJ Vink, ...
European Respiratory Journal 44 (1), 188-197, 2014
1242014
The system can't perform the operation now. Try again later.
Articles 1–20